Harikrishna Reddy Rallabandi1, Hyeon Yang1, Keon Bong Oh1, Hwi Cheul Lee1, Sung June Byun1, Bo Ram Lee2. 1. Animal Biotechnology Division, National Institute of Animal Science, Rural Development Administration, 1500 Kongjwipatjwi-ro, Iseo-myeon, Wanju-gun, Jeollabuk-do, 55365, Republic of Korea. 2. Animal Biotechnology Division, National Institute of Animal Science, Rural Development Administration, 1500 Kongjwipatjwi-ro, Iseo-myeon, Wanju-gun, Jeollabuk-do, 55365, Republic of Korea. mir88@korea.kr.
Abstract
BACKGROUND: Intestinal organoids have evolved as potential molecular tools that could be used to study host-microbiome interactions, nutrient uptake, and drug screening. Gut epithelial barrier functions play a crucial role in health and diseases, especially in autoimmune diseases, such as inflammatory bowel diseases (IBDs), because they disrupt the epithelial mucosa and impair barrier function. METHODS: In this study, we generated an in vitro IBD model based on dextran sodium sulfate (DSS) and intestinal organoids that could potentially be used to assess barrier integrity. Intestinal organoids were long-term cultivated and characterized with several specific markers, and the key functionality of paracellular permeability was determined using FITC-dextran 4 kDa. Intestinal organoids that had been treated with 2 µM DSS for 3 h were developed and the intestinal epithelial barrier function was sequentially evaluated. RESULTS: The results indicated that the paracellular permeability represented epithelial characteristics and their barrier function had declined when they were exposed to FITC-dextran 4 kDa after DSS treatment. In addition, we analyzed the endogenous mRNA expression of pro-inflammatory cytokines and their downstream effector genes. The results demonstrated that the inflammatory cytokines genes significantly increased in inflamed organoids compared to the control, leading to epithelial barrier damage and dysfunction. CONCLUSION: The collective results showed that in vitro 3D organoids mimic in vivo tissue topology and functionality with minor limitations, and hence are helpful for testing disease models.
BACKGROUND: Intestinal organoids have evolved as potential molecular tools that could be used to study host-microbiome interactions, nutrient uptake, and drug screening. Gut epithelial barrier functions play a crucial role in health and diseases, especially in autoimmune diseases, such as inflammatory bowel diseases (IBDs), because they disrupt the epithelial mucosa and impair barrier function. METHODS: In this study, we generated an in vitro IBD model based on dextran sodium sulfate (DSS) and intestinal organoids that could potentially be used to assess barrier integrity. Intestinal organoids were long-term cultivated and characterized with several specific markers, and the key functionality of paracellular permeability was determined using FITC-dextran 4 kDa. Intestinal organoids that had been treated with 2 µM DSS for 3 h were developed and the intestinal epithelial barrier function was sequentially evaluated. RESULTS: The results indicated that the paracellular permeability represented epithelial characteristics and their barrier function had declined when they were exposed to FITC-dextran 4 kDa after DSS treatment. In addition, we analyzed the endogenous mRNA expression of pro-inflammatory cytokines and their downstream effector genes. The results demonstrated that the inflammatory cytokines genes significantly increased in inflamed organoids compared to the control, leading to epithelial barrier damage and dysfunction. CONCLUSION: The collective results showed that in vitro 3D organoids mimic in vivo tissue topology and functionality with minor limitations, and hence are helpful for testing disease models.
Entities:
Keywords:
Epithelial barrier; Ex vivo model; IBD; Intestinal stem cells; Organoids
Authors: Kelley S Yan; Luis A Chia; Xingnan Li; Akifumi Ootani; James Su; Josephine Y Lee; Nan Su; Yuling Luo; Sarah C Heilshorn; Manuel R Amieva; Eugenio Sangiorgi; Mario R Capecchi; Calvin J Kuo Journal: Proc Natl Acad Sci U S A Date: 2011-12-21 Impact factor: 11.205
Authors: Toshiro Sato; Daniel E Stange; Marc Ferrante; Robert G J Vries; Johan H Van Es; Stieneke Van den Brink; Winan J Van Houdt; Apollo Pronk; Joost Van Gorp; Peter D Siersema; Hans Clevers Journal: Gastroenterology Date: 2011-09-02 Impact factor: 22.682
Authors: J Jasper Deuring; Colin de Haar; Ernst J Kuipers; Maikel P Peppelenbosch; C Janneke van der Woude Journal: Int J Biochem Cell Biol Date: 2013-01-03 Impact factor: 5.085
Authors: Jamie J Kopper; Chelsea Iennarella-Servantez; Albert E Jergens; Dipak K Sahoo; Emilie Guillot; Agnes Bourgois-Mochel; Marilyn N Martinez; Karin Allenspach; Jonathan P Mochel Journal: Front Toxicol Date: 2021-11-10
Authors: Charles K Crawford; Veronica Lopez Cervantes; Mary L Quilici; Aníbal G Armién; María Questa; Muhammad S Matloob; Leon D Huynh; Aeelin Beltran; Sophie J Karchemskiy; Katti R Crakes; Amir Kol Journal: Sci Rep Date: 2022-08-26 Impact factor: 4.996
Authors: Daniel P Brice; Graeme I Murray; Heather M Wilson; Ross J Porter; Susan Berry; Scott K Durum; Mairi H McLean Journal: Biology (Basel) Date: 2022-03-11